Patents
Patents for C07K 19 - Hybrid peptides (29,428)
03/2008
03/12/2008CN101139590A Hybrid expression of neisserial proteins
03/12/2008CN101139556A Highly effective production method for recombinant alpha-glucanase fusion protein and related expression carrier and bacterial strain
03/12/2008CN101139399A Fused protein restructuring target lethal leukemia cells and preparation method and use thereof
03/12/2008CN100374460C Bacteriophage containing short-peptide specifically combined with avian infectious bronchitis virus and use thereof
03/11/2008US7342090 Peptide-mimetics are constrained in the three-dimensional structure to provide an increased immunogenicity to the epitope sequence
03/11/2008US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/11/2008US7341842 TRP8, a transient receptor potential channel expressed in taste receptor cells
03/11/2008US7341730 Inhibitors of angiogenesis and tumor growth
03/11/2008US7341728 Internalisation of virus into cells
03/11/2008CA2331764C Polyketides and their synthesis
03/11/2008CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
03/08/2008CA2622504A1 Methods and compositions for inhibiting cell death or enhancing cel proliferation
03/06/2008WO2008026852A1 Fusion polypeptide for inhibiting neurotransmitter secretion and method for delivering it
03/06/2008WO2008025163A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity
03/06/2008WO2008025067A1 Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same
03/06/2008WO2008006458A3 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them
03/06/2008WO2007109749A3 Methods for preventing and treating amyloidogenic diseases
03/06/2008US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders
03/06/2008US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators
03/06/2008US20080058261 Protease susceptibility II
03/06/2008US20080057565 Method for overexpression of zwitterionic polysaccharides
03/06/2008US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer
03/06/2008CA2662026A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity
03/05/2008EP1895017A2 Use of A33 antigens and JAM-IT
03/05/2008EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
03/05/2008EP1893650A2 Hiv tat-cd4 hybried molecules and methods of use thereof
03/05/2008CN101137674A Chimeric recombinant antigens of toxoplasma gondii
03/05/2008CN101134781A Recombinant fusion protein carrying anthrax protective antigens epitope inserted to hepatitis B core antigen protein or its fragment and uses thereof
03/05/2008CN101134780A Polypeptide analogue for blocking NR2B signal path and preparation method and medical usage thereof
03/05/2008CN101134775A Novel streptococcus antigens
03/04/2008US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes
03/01/2008CA2598060A1 Methods and compositions for the treatment and prevention of cancer
03/01/2008CA2597840A1 Methods and compositions for the treatment and prevention of cancer
02/2008
02/28/2008WO2008023689A1 Method of producing fused protein
02/28/2008WO2007137586A3 Random insertion of peptides
02/28/2008US20080051555 Support Having Affinity for Antibody
02/28/2008US20080051356 Truncated 24kDa basic fibroblast growth factor
02/28/2008US20080051299 DNA-protein fusions and uses thereof
02/28/2008US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders
02/28/2008US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
02/28/2008US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents
02/28/2008US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia
02/28/2008US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
02/27/2008EP1892296A1 Generation and selection of recombinant varied binding proteins
02/27/2008EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
02/27/2008EP1891975A1 Anti-allergic complex molecules
02/27/2008EP1891969A2 Novel anti-allergic agents
02/27/2008EP1261723B1 Hybrid expression of neisserial proteins
02/27/2008CN101133083A 人源化的抗cd47抗体 Humanized anti-cd47 antibody
02/27/2008CN101132813A BLYS fusion proteins for targeting BLYS receptor and methods for treatment of B-cell proliferative disorders
02/27/2008CN100371442C Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen
02/27/2008CN100371349C Recombination immune therapeutic protein and its expression method and application
02/26/2008US7335492 Process for partitioning of proteins
02/26/2008US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus
02/21/2008WO2006136084A8 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses
02/21/2008US20080045695 Fusion Protein Suitable to be Expressed High Effectively and the Production Method thereof
02/21/2008US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
02/21/2008US20080044412 Single-Domain Antibody Strengthening Fusion Protein Vh-Ldp-Ae
02/21/2008CA2660178A1 Promiscuous her-2/neu cd4 t cell epitopes
02/20/2008EP1889908A1 Anti-cd14 antibody-fused protein
02/20/2008EP1888641A1 Serum albumin binding proteins
02/20/2008EP1888625A2 Malaria vaccines
02/20/2008EP1888111A1 Modulation of cholesteryl ester transfer protein (cetp) activity
02/20/2008EP1121437B1 Metastatic breast and colon cancer regulated genes
02/20/2008EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis
02/20/2008EP0731806B2 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
02/20/2008EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
02/20/2008CN101128480A Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid
02/20/2008CN101125891A TAT-PEIII fusion protein used for tumor partial interventional therapy and preparation method thereof
02/19/2008US7332598 of given nucleotide sequence; contains mutation(s) that reduces or eliminates the ability of the green fluorescent protein to oligomerize; reporter molecules; eliminates false positives in analysis due to self-association; fusion proteins, vectors and host cells
02/19/2008US7332587 Separation of target molecule from sample; obtain sample, incubate with oli bodies, isolate oil body bound target
02/19/2008US7332474 Peptides and related compounds having thrombopoietic activity
02/19/2008US7332168 Composition for the elimination of autoreactive B-cells
02/14/2008WO2008018562A1 Production of useful protein such as antibody having modified sugar chain in egg yolk of transgenic chicken
02/14/2008WO2007084021A3 Compositions and methods for diagnosing hiv-2 infection
02/14/2008WO2007059715A8 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
02/14/2008US20080039392 CRAC channel and modulator screening methods
02/14/2008US20080039386 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell
02/14/2008US20080038741 T1R taste receptors and genes encoding same
02/14/2008US20080038717 Enrichment method for variant proteins with altered binding properties
02/14/2008US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection
02/14/2008US20080038264 Compositions and methods for the treatment of immune related diseases
02/13/2008EP1887014A1 Human toll homologues
02/13/2008EP1885744A2 Novel substrate for rpn 11 enzymatic activity
02/13/2008EP1207200B1 High affinity choline transporter
02/13/2008EP1005549B1 Prostate tumor polynucleotide and antigen compositions
02/13/2008CN101121754A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
02/13/2008CN101121753A Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell
02/13/2008CN101121752A Short peptide fusion expression heat induced recombinant plasmid using streptavidin as carrier and preparation method thereof
02/13/2008CN101121751A PTD-tyrosine hydroxylase catalysis region fusion protein and application thereof
02/13/2008CN101121020A Anti-gp39 antibodies and its uses
02/13/2008CN100368546C Food-poisoning fungus concatenated fusion mycinamicin and use thereof
02/13/2008CN100368438C Anti-hepatitis B virus fusion protein and its coding gene and application
02/13/2008CN100368437C Recombinant antigen protein for diagnosing ox tuberculosis and its prepn process
02/12/2008US7329735 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits
02/12/2008US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof
02/12/2008US7329728 Ligand activated transcriptional regulator proteins
02/12/2008US7329541 Zinc finger binding domains for GNN
02/12/2008US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments
02/12/2008US7329494 Method of detection and quantification of cGMP by using a cGMP-visualizing probe